Efficacy of Probiotic Therapy on Atopic Dermatitis in Adults Depends on the C-159T Polymorphism of the CD14 Receptor Gene - A Pilot Study
DOI:
https://doi.org/10.3889/oamjms.2019.242Keywords:
atopic dermatitis, Probiotics, C-159T polymorphism, CytokinesAbstract
BACKGROUND: The C-159T polymorphism of the CD14 receptor gene can be associated with the development of atopic dermatitis. Probiotics can modulate chronic inflammation through activation of the CD14 receptor. So, the efficacy of probiotic therapy can be dependent on this genetic polymorphism.
AIM: The purpose of the study was to investigate the efficacy of adding probiotic (Lactobacillus acidophilus, LA-5 and Bifidobacterium animalis subsp. lactis, Ð’Ð’-12) to standard treatment (ointment of fluticasone propionate 0.005% and emollient) of atopic dermatitis in adults during 28 days, depending on the stratification of patients on CC or TT genotypes of the CD14 receptor gene.
MATERIAL AND METHODS: The study included 37 adult patients with AD. There were identified 19 patients with exogenous (IgE-dependent) and 18 with endogenous (IgE-dependent) AD. To evaluate the efficacy of the probiotics all patients were divided into three groups for both exogenous and endogenous AD. The first group was selected from patients with CC genotype (C-159T) who received standard therapy (ointment of fluticasone propionate 0.005% – 2 times a day, emollients – 2 times a day) and probiotic (Lactobacillus acidophilus, LA-5 and Bifidobacterium animalis subsp. lactis, ВВ-12 - 1 capsule 2 times per day) The second group included patients with CC genotype, who received only standard therapy. The third group was presented by patients with TT genotype (C-159T) who received standard therapy and probiotic. The SCORAD and DLQI parameters were evaluated on Day 0, 14 and 28. The level of IL-4, IL-5, IL-10, TGF-β cytokines was determined on Day 0 and Day 28.
RESULTS: The results of our study found that the addition of probiotics (Lactobacillus acidophilus, LA-5 and Bifidobacterium animalis subsp. lactis, ВВ-12) to standard treatment (ointment of fluticasone propionate 0.005%, emollient) significantly increased the effectiveness of treatment of atopic dermatitis in adults with exogenous form and CC genotype (C-159T), confirmed by clinical (a significant decrease of SCORAD and DLQI indices) and immunological criteria (a significant decrease of IL-4 and an increase of TGF-β).
CONCLUSION: Simultaneous determination of the exogenous or endogenous form, identification of the C-159T genotypes, evaluation of the serum level of IL-4 and TGF-β can serve as an algorithm for the personalised treatment of patients with atopic dermatitis.
Downloads
Metrics
Plum Analytics Artifact Widget Block
References
Pineiro M, Asp NG, Reid G, Macfarlane S, Morelli L, Brunser O, et al. FAO Technical meeting on prebiotics. J Clin Gastroenterol. 2008; 42(Suppl 3, Pt 2):S156-9. https://doi.org/10.1097/MCG.0b013e31817f184e PMid:18685504
Sánchez B, Delgado S, Blanco-MÃguez A, Lourenço A, Gueimonde M, Margolles A. Probiotics, gut microbiota, and their influence on host health and disease. Mol Nutr Food Res. 2017; 61(1). https://doi.org/10.1002/mnfr.201600240
Baldini M, Lohman IC, Halonen M, Erickson RP, Holt PG, Martinez FD. A Polymorphism* in the 5' flanking region of the CD14 gene is associated with circulating solubleCD14 levels and with total serum immunoglobulin E. Am J Respir Cell Mol Biol. 1999; 20(5):976-83. https://doi.org/10.1165/ajrcmb.20.5.3494 PMid:10226067
Zhao L, Bracken MB. Association of CD14 -260 (-159) C>T and asthma: a systematic review and meta-analysis. BMC Med Genet. 2011; 12:93. https://doi.org/10.1186/1471-2350-12-93 PMid:21745379 PMCid:PMC3148550
Leynaert B, Guilloud-Bataille M, Soussan D, Benessiano J, Guénégou A, Pin I, et al. Association between farm exposure and atopy, according to the CD14 C-159T polymorphism. J Allergy Clin Immunol. 2006; 118(3):658-65. https://doi.org/10.1016/j.jaci.2006.06.015 PMid:16950285
Rennie DC, Karunanayake CP, Chen Y, Nakagawa K, Pahwa P, Senthilselvan A, et al. CD14 gene variants and their importance for childhood croup, atopy, and asthma. Dis Markers. 2013; 35(6):765-71. https://doi.org/10.1155/2013/434920 PMid:24347797 PMCid:PMC3856132
Koppelman GH, Reijmerink NE, Colin Stine O, Howard TD, Whittaker PA, Meyers DA, et al. Association of a promoter polymorphism of the CD14 gene and atopy. Am J Respir Crit Care Med. 2001; 163(4):965-9. https://doi.org/10.1164/ajrccm.163.4.2004164 PMid:11282774
O'Donnell AR, Toelle BG, Marks GB, Hayden CM, Laing IA, Peat JK, et al. Age-specific relationship between CD14 and atopy in a cohort assessed from age 8 to 25 years. Am J Respir Crit Care Med. 2004; 169(5):615-22. https://doi.org/10.1164/rccm.200302-278OC PMid:14617510
Leung TF, Tang NL, Sung YM, Li AM, Wong GW, Chan IH, et al. The C-159T polymorphism in the CD14 promoter is associated with serum total IgE concentration in atopic Chinese children. Pediatr Allergy Immunol. 2003; 14(4):255-60. https://doi.org/10.1034/j.1399-3038.2003.00048.x PMid:12911501
Han D, She W, Zhang L. Association of the CD14 gene polymorphism C-159T with allergic rhinitis. Am J Rhinol Allergy. 2010; 24(1):e1-3. https://doi.org/10.2500/ajra.2010.24.3411 PMid:20109306
Kabesch M, Hasemann K, Schickinger V, Tzotcheva I, Bohnert A, Carr D, et al. A promoter polymorphism in the CD14 gene is associated with elevated levels of soluble CD14 but not with IgE or atopic diseases. Allergy. 2004; 59(5):520-5. https://doi.org/10.1111/j.1398-9995.2004.00439.x PMid:15080833
Zare Marzouni H, Farid-Hosseini R, Jabari-Azad F, Tavakkol-Afshari J, Tehranian F, Khoshkhui M, et al. CD14 as A Serum Immune Biomarker and Genetic Predisposition Factor for Allergic Rhinitis. Iran J Otorhinolaryngol. 2019; 31(102):1-9. PMid:30783593 PMCid:PMC6368989
Wang IJ, Wang JY. Children with atopic dermatitis show clinical improvement after Lactobacillus exposure. Clin Exp Allergy. 2015; 45(4):779-87. https://doi.org/10.1111/cea.12489 PMid:25600169
Bieber T, Vieths S, Broich K. New opportunities and challenges in the assessment of drugs for atopic diseases. Allergy. 2016; 71(12):1662-1665. https://doi.org/10.1111/all.13063 PMid:27716946
Wollenberg A, Barbarot S, Bieber T, Christen-Zaech S, Deleuran M, Fink-Wagner A, et al. Consensus-based European guidelines for treatment of atopic eczema (atopic dermatitis) in adults and children: part I. J Eur Acad Dermatol Venereol. 2018; 32(5):657-682. https://doi.org/10.1111/jdv.14891 PMid:29676534
Gerbens LA, Chalmers JR, Rogers NK, Nankervis H, Spuls PI;Harmonising Outcome Measures for Eczema (HOME) initiative. Reporting of symptoms in randomized controlled trials of atopic eczema treatments: a systematic review. Br J Dermatol. 2016; 175(4):678-86. https://doi.org/10.1111/bjd.14588 PMid:27012805
Hongbo Y, Thomas CL, Harrison MA, Salek MS, Finlay AY. Translating the science of quality of life into practice: What do dermatology life quality indexscores mean? J Invest Dermatol. 2005; 125(4):659-64. https://doi.org/10.1111/j.0022-202X.2005.23621.x PMid:16185263
Ballini A, Santacroce L, Cantore S, Bottalico L, Dipalma G, Topi S, et al. Probiotics Efficacy on Oxidative Stress Values in Inflammatory Bowel Disease: A Randomized Double-Blinded Placebo-Controlled Pilot Study. Endocr Metab Immune Disord Drug Targets, 2018. https://doi.org/10.2174/1871530319666181221150352
Campanella V, Syed J, Santacroce L, Saini R, Ballini A, Inchingolo F. Oral probiotics influence oral and respiratory tract infections in pediatric population: a randomized double-blinded placebo-controlled pilot study. Eur Rev Med Pharmacol Sci. 2018; 22(22):8034-8041. PMid:30536353
Baquerizo Nole KL, Yim E, Keri JE. Probiotics and prebiotics in dermatology. J Am Acad Dermatol. 2014; 71(4):814-21. https://doi.org/10.1016/j.jaad.2014.04.050 PMid:24906613
Winkler P, Ghadimi D, Schrezenmeir J, Kraehenbuhl JP. Molecular and cellular basis of microflora-host interactions. Nutr. 2007; 137(3 Suppl 2):756S-72S. https://doi.org/10.1093/jn/137.3.756S PMid:17311973
Feleszko W, Jaworska J, Rha RD, Steinhausen S, Avagyan A, Jaudszus A, et al. Probiotic-induced suppression of allergic sensitization and airway inflammation is associated with an increase of T regulatory-dependent mechanisms in a murine model of asthma. Clin Exp Allergy. 2007; 37(4):498-505. https://doi.org/10.1111/j.1365-2222.2006.02629.x PMid:17430345
Karimi K, Inman MD, Bienenstock J, Forsythe P. Lactobacillus reuteri-induced regulatory T cells protect against an allergic airway response in mice. Am J Respir Crit Care Med. 2009; 179(3):186-93. https://doi.org/10.1164/rccm.200806-951OC PMid:19029003
Kwon HK, Lee CG, So JS, Chae CS, Hwang JS, Sahoo A, et al. Generation of regulatory dendritic cells and CD4+Foxp3+ T cells by probiotics administrationsuppresses immune disorders. Proc Natl Acad Sci U S A. 2010; 107(5):2159-64. https://doi.org/10.1073/pnas.0904055107 PMid:20080669 PMCid:PMC2836639
Drago L, Iemoli E, Rodighiero V, Nicola L, De Vecchi E, Piconi S. Effects of Lactobacillus salivarius LS01 (DSM 22775) treatment on adult atopic dermatitis: a randomized placebo-controlled study. Int J Immunopathol Pharmacol. 2011; 24(4):1037-48. https://doi.org/10.1177/039463201102400421 PMid:22230409
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2019 Oleksandr Litus, Nadiya Derkach, Viktor Litus, Yuriy Bisyuk, Bohdan Lytvynenko
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
http://creativecommons.org/licenses/by-nc/4.0
